At a glance
ClinicalIndex Comparison RecordN/ACompleted· 200 enrolled
Drug / intervention
Cease progsterone at 5 +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Early Progesterone Cessation After in Vitro Fertilization
In Brief
A clinical study evaluating Cease progsterone at 5 and control group: progesterone 8 for Pregnant Women. Completed, enrolled 200 participants across 1 site.
Detailed Summary
There seems to be a general consensus on the supplementation of progesterone (P4) for luteal phase support (LPS) to all women after in vitro fertilization (IVF) treatment. However, there is no agreement about the precise duration of LPS.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPregnant Women
CountriesSpain
Collaborators--
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJan 2009
Primary CompletionJan 2010
First PostedAug 2010
TodayJul 2026
First PostedAug 9, 2010
Enrollment StartJan 1, 2009
Primary CompletionJan 1, 2010
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 15.9 years ago
Interventions
Cease progsterone at 5other
Cease administration of progsterone at first US at 5 weeks
control group: progesterone 8other
Control group: progesterone until 8 weeks of pregnancy